Literature DB >> 3667888

Circulating immunoreactive inhibin levels during the normal human menstrual cycle.

R I McLachlan1, D M Robertson, D L Healy, H G Burger, D M de Kretser.   

Abstract

Serum inhibin concentrations were measured daily by RIA in six normal women throughout one menstrual cycle. The RIA was specific for inhibin, and inhibin subunits and related proteins cross-reacted minimally in it. In the early to midfollicular phase, inhibin levels changed little, while in the late follicular phase, inhibin levels rose, in parallel with estradiol (r = 0.43; P less than 0.05; n = 22), to a peak level of 714 (407-1267) U/L (geometric mean +/- 67% confidence limits) coincident with the midcycle LH and FSH surges. An inverse relationship was found between serum inhibin and FSH during the mid- to late follicular phase (r = 0.42; P less than 0.01; n = 45). Inhibin levels rose further during the luteal phase to a peak level of 1490 (1086-2028) U/L 7-8 days after the LH surge, and they correlated positively with serum progesterone (r = 0.76; P less than 0.001; n = 49) and inversely with serum FSH (r = 0.43; P less than 0.01; n = 49) throughout the luteal phase. We conclude that 1) circulating inhibin is detectable throughout the normal menstrual cycle; 2) in the late follicular phase, inhibin levels rise in parallel with estradiol, consistent with the concept that both are products of the maturing follicle; 3) in the luteal phase, the profile of inhibin suggests that it is a secretory product of the corpus luteum; and 4) the inverse relationship between inhibin and FSH in the follicular phase is consistent with the inhibin hypothesis, while at midcycle there is loss of the inhibitory effect of inhibin on FSH secretion. The inverse relationship between FSH and inhibin during the luteal phase suggests a hitherto unsuspected role for inhibin in the feedback regulation of FSH secretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3667888     DOI: 10.1210/jcem-65-5-954

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Expression of inhibin/activin alpha, betaA and betaB subunits in the ovary of the bitch.

Authors:  G Marino; A Zanghì; G Catone; R A Bontempo; P A Nicòtina
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

Review 2.  Recent advances in the human physiology of inhibin secretion.

Authors:  D M de Kretser; D M Robertson; G P Risbridger
Journal:  J Endocrinol Invest       Date:  1990 Jul-Aug       Impact factor: 4.256

Review 3.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

4.  Immunohistochemical staining of normal, hyperplastic, and neoplastic adrenal cortex with a monoclonal antibody against alpha inhibin.

Authors:  W G McCluggage; J Burton; P Maxwell; J M Sloan
Journal:  J Clin Pathol       Date:  1998-02       Impact factor: 3.411

Review 5.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

6.  Ovulation block by Pueraria mirifica: a study of its endocrinological effect in female monkeys.

Authors:  Hataitip Trisomboon; Suchinda Malaivijitnond; Gen Watanabe; Kazuyoshi Taya
Journal:  Endocrine       Date:  2005-02       Impact factor: 3.633

7.  Malignant fibrothecomatous tumour of the ovary: diagnostic value of anti-inhibin immunostaining.

Authors:  W G McCluggage; J M Sloan; D D Boyle; P G Toner
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

8.  The utility of serum progesterone and inhibin A for monitoring natural-cycle IVF-ET.

Authors:  S R Lindheim; P L Chang; A Vidali; M Ferin; M V Sauer
Journal:  J Assist Reprod Genet       Date:  1998-10       Impact factor: 3.412

9.  Relative roles of follicle-stimulating hormone and luteinizing hormone in the control of inhibin secretion in normal men.

Authors:  R I McLachlan; A M Matsumoto; H G Burger; D M de Kretser; W J Bremner
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

10.  Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition.

Authors:  MaryFran R Sowers; Aimee D Eyvazzadeh; Daniel McConnell; Matheos Yosef; Mary L Jannausch; Daowen Zhang; Sioban Harlow; John F Randolph
Journal:  J Clin Endocrinol Metab       Date:  2008-07-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.